Purdue’s Presidential Lecture Series features Timothy Ferris, Lisa Su, Shantanu Narayen and Bruce Leak in free spring events.

Scientists discovered why some neurons resist tau toxicity, identifying CRL5SOCS4 as a crucial defense and linking ...

The University of Georgia has scheduled a series of lectures this semester, including winners of the Nobel Prize and the Pulitzer Prize. The Signature Lectures begin in February and conclude in April.

Dr. Hong Li, professor in Van Andel Institute’s Department of Structural Biology, leverages CRISPR, cryo-EM and other leading-edge technologies to explore the mechanisms underlying RNA-mediated ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

Plus: Grok is restricting its image-generating function to paid subscribers only This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act like molecular anchors. The work confirms these tags actively silence genes, ...

CRISPR biosensors are transforming healthcare by detecting biomarkers at attomolar sensitivity, enabling real-time health monitoring through wearable patches and implantable sensors. They continuously ...

Researchers have successfully resurrected a gene that humanity lost millions of years ago. The results could change how we treat common diseases such as gout and maybe even contribute to slowing down ...

Chicago-based CRISPR technology company Syntax Bio says it has developed tech that automates the slow, manual process of generating functional cell types, which may usher in a new generation of cell ...

For a decade after its discovery, CRISPR gene editing was stuck on the cusp of transforming medicine. Then, in 2023, scientists started using it on sickle-cell disease, and Victoria Gray, a patient ...